BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing. The Interventional Medicine segment includes oncology, vascular and pulmonology. The segment's products include Beads, TheraSphere, EkoSonic, Varithena and PneumRx Coils for use in the treatment of liver tumors, blood clots, varicose veins and advanced emphysema. The Specialty Pharmaceuticals segment includes CroFab, DigiFab, Voraxaze and Vistogard products for use in the treatment of crotalid envenomation, digoxin toxicity, high-dose methotrexate toxicity and 5-fluorouracil toxicity. The Licensing segment includes Zytiga, Two-Part Hip Cup and Lemtrada products for use in the treatment of advanced prostate cancer, hip replacement and multiple sclerosis.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Pharmaceuticals - NEC
- Sub-Industry: N/A
- Symbol: LON:BTG
- CUSIP: N/A
- Web: www.btgplc.com
Capitalization:- Market Cap: £2.56 billion
- Outstanding Shares: 385,095,000
Average Prices:- 50 Day Moving Avg: GBX 665.26
- 200 Day Moving Avg: GBX 634.02
- 52 Week Range: GBX 528.36 - GBX 738.50
P/E:- Trailing P/E Ratio: 77.21
- P/E Growth: 1.14
Sales & Book Value:- Annual Revenue: £570.5 million
- Price / Sales: 4.48
- Book Value: GBX 2.55 per share
- Price / Book: 2.60
Profitability:- EBIDTA: £135.3 million
- Net Margins: 7.26%
- Return on Equity: 4.33%
- Return on Assets: 3.18%
Misc:- Average Volume: 605,740 shs.
Frequently Asked Questions for BTG plc (LON:BTG)
What is BTG plc's stock symbol?
BTG plc trades on the London Stock Exchange (LON) under the ticker symbol "BTG."
Where is BTG plc's stock going? Where will BTG plc's stock price be in 2017?
9 equities research analysts have issued 12 month target prices for BTG plc's stock. Their predictions range from GBX 630 to GBX 900. On average, they anticipate BTG plc's share price to reach GBX 766.44 in the next year. View Analyst Ratings for BTG plc.
Who are some of BTG plc's key competitors?
Some companies that are related to BTG plc include Dr. Reddy's Laboratories Ltd (RDY), Patheon NV (PTHN), Valeant Pharmaceuticals International (VRX), Catalent (CTLT), Taro Pharmaceutical Industries (TARO), Akorn (AKRX), Opko Health (OPK), Hikma Pharmaceuticals Plc (HIK), Horizon Pharma PLC (HZNP), Amicus Therapeutics (FOLD), Cambrex Corporation (CBM), Corcept Therapeutics Incorporated (CORT), Theravance Biopharma (TBPH), Pacira Pharmaceuticals (PCRX), Emergent Biosolutions (EBS), Innoviva (INVA), Impax Laboratories (IPXL) and AKCEA THERAPEUT (AKCA).
Who are BTG plc's key executives?
BTG plc's management team includes the folowing people:
- Dame Pamela Louise Makin Ph.D., Chief Executive Officer, Executive Director
- Rolf B. Soderstrom, Chief Financial Officer, Executive Director
- Paul Mussenden, Company Secretary
- Garry Andrew Watts, Non-Executive Chairman of the Board
- Susan Elizabeth Foden Ph.D., Non-Executive Director
- Graham Hetherington, Non-Executive Director
- Giles Francis Bertram Kerr, Senior Independent Non-Executive Director
- Ian F. R. Much, Independent Non-Executive Director
How do I buy BTG plc stock?
Shares of BTG plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is BTG plc's stock price today?
One share of BTG plc stock can currently be purchased for approximately GBX 664.
MarketBeat Community Rating for BTG plc (LON BTG)MarketBeat's community ratings are surveys of what our community members think about BTG plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for BTG plc (LON:BTG) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 3 Hold Ratings, 6 Buy Ratings |
| Consensus Rating: | Buy (Score: 2.67) |
| Consensus Price Target: | GBX 766.44 |
Analysts' Ratings History for BTG plc (LON:BTG)
Show:
| Date | Firm | Action | Rating | Price Target | Details |
|---|
| 8/9/2017 | Numis Securities Ltd | Reiterated Rating | Buy | GBX 900 |  |
| 7/13/2017 | Shore Capital | Reiterated Rating | not rated | | |
| 7/4/2017 | J P Morgan Chase & Co | Reiterated Rating | Neutral | GBX 790 | |
| 5/22/2017 | Panmure Gordon | Lower Price Target | Buy | GBX 809 -> GBX 793 | |
| 5/18/2017 | Deutsche Bank AG | Reiterated Rating | Buy | GBX 775 | |
| 5/16/2017 | Jefferies Group LLC | Reiterated Rating | Buy | GBX 775 | |
| 5/16/2017 | Peel Hunt | Reiterated Rating | Hold | GBX 630 | |
| 4/6/2017 | Investec | Reiterated Rating | Buy | GBX 720 | |
| 4/4/2017 | Stifel Nicolaus | Reiterated Rating | Buy | GBX 725 | |
| 11/1/2016 | Royal Bank Of Canada | Downgrade | Sector Performer | GBX 910 -> GBX 790 | |
| 10/8/2015 | FinnCap | Reiterated Rating | Hold | | |
(Data available from 8/20/2015 forward)
Earnings History for BTG plc (LON:BTG)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for BTG plc (LON:BTG)Current Year EPS Consensus Estimate: $29.54 EPS
Dividend History for BTG plc (LON:BTG)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for BTG plc (LON:BTG)Insider Trades by Quarter for BTG plc (LON:BTG)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 6/9/2017 | Rolf Soderstrom | Insider | Sell | 22,624 | GBX 649 | £146,829.76 | |
| 6/1/2017 | Rolf Soderstrom | Insider | Sell | 129,514 | GBX 655 | £848,316.70 | |
| 7/21/2016 | Soderstrom,Rolf | Insider | Sell | 74,327 | GBX 676 | £502,450.52 | |
| 7/6/2016 | Makin,Dame Pamela Louise | Insider | Sell | 256,404 | GBX 695 | £1,782,007.80 | |
| 6/3/2015 | Rolf Soderstrom | Insider | Sell | 35,225 | GBX 704.88 | £248,293.98 | |
(Data available from 1/1/2013 forward)
Headline Trends for BTG plc (LON:BTG)
Latest Headlines for BTG plc (LON:BTG)
| Source: |
|
| Date | Headline |
|---|
 | BTG plc (LON:BTG) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - August 8 at 6:32 AM |
| BTG plc (BTG) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - July 14 at 8:18 AM |
| BTG plc (BTG) Rating Reiterated by Shore Capital
www.americanbankingnews.com - July 13 at 3:06 PM |
 | BTG Says Current Trading In Line With View; Backs FY Guidance - Quick Facts
www.rttnews.com - July 13 at 3:28 AM |
 | BTG forsees double-digit product sales growth - MarketWatch
www.marketwatch.com - July 13 at 3:28 AM |
 | The Dollar and Precious Metals on Friday, July 7
finance.yahoo.com - July 11 at 5:46 PM |
| Numis Securities Ltd Reaffirms Buy Rating for BTG plc (BTG)
www.americanbankingnews.com - June 29 at 9:00 AM |
| What Happened to Precious Metals prior to Yellen’s Speech?
finance.yahoo.com - June 27 at 4:17 PM |
| How Are the Fund Flows to the GLD ETF?
finance.yahoo.com - June 23 at 4:42 PM |
| How Are the Fund Flows to the GLD ETF?
finance.yahoo.com - June 23 at 4:42 PM |
| BTG plc (BTG) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - June 19 at 7:54 AM |
| BTG Plc :BTG-GB: Earnings Analysis: 2017 By the Numbers : June 16, 2017
finance.yahoo.com - June 16 at 9:48 PM |
| BTG Plc :BTG-GB: Earnings Analysis: For the six months ended March 31, 2017 : June 16, 2017
finance.yahoo.com - June 16 at 9:48 PM |
| ACCESS PTS Study Demonstrates Efficacy of EKOS® Therapy for Post-Thrombotic Syndrome
finance.yahoo.com - June 16 at 4:47 PM |
| BTG Plc : Neutral assessment on price but strong on fundamentals
finance.yahoo.com - June 16 at 4:47 PM |
| BTG Plc – Value Analysis (LONDON:BTG) : June 15, 2017
finance.yahoo.com - June 15 at 5:56 PM |
| BTG plc's (BTG) "Buy" Rating Reiterated at Numis Securities Ltd
www.americanbankingnews.com - June 14 at 10:26 AM |
 | New Study Shows Patients Treated With CroFab® Have Improved ... - PR Newswire (press release)
www.prnewswire.com - June 13 at 12:55 PM |
| New Study Shows Patients Treated With CroFab® Have Improved Recovery From Copperhead Envenomation
finance.yahoo.com - June 13 at 12:55 PM |
| BTG plc (BTG) Insider Sells £146,829.76 in Stock
www.americanbankingnews.com - June 12 at 1:38 PM |
| New Study Shows IO Loop™ Improves Patient Follow-up, Engagement and Satisfaction Following Treatment With TheraSphere®
finance.yahoo.com - June 10 at 4:07 PM |
| SIO Announces First Grants in Interventional Oncology / Immuno-Oncology Research Programme - PR Newswire (press release)
www.prnewswire.com - June 7 at 12:05 PM |
| SIO Announces First Grants in Interventional Oncology / Immuno-Oncology Research Programme
finance.yahoo.com - June 7 at 12:05 PM |
| Rolf Soderstrom Sells 129,514 Shares of BTG plc (BTG) Stock
www.americanbankingnews.com - June 2 at 7:34 AM |
 | Australia's Second Worst-Performing Stock May Have a Silver Lining
www.bloomberg.com - June 1 at 9:34 PM |
| BTG Plc breached its 50 day moving average in a Bullish Manner : BTG-GB : May 29, 2017
finance.yahoo.com - May 29 at 10:46 AM |
| BTG plc (BTG) PT Raised to GBX 809
www.americanbankingnews.com - May 28 at 5:14 PM |
| BTG plc (BTG) Given Buy Rating at Jefferies Group LLC
www.americanbankingnews.com - May 28 at 5:14 PM |
| JPMorgan Chase & Co. Reaffirms Neutral Rating for BTG plc (BTG)
www.americanbankingnews.com - May 28 at 7:14 AM |
| How Funds Are Flowing to Gold in 2017
finance.yahoo.com - May 24 at 8:57 PM |
| BTG plc (BTG) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - May 23 at 7:04 AM |
| BTG plc (BTG) PT Lowered to GBX 793 at Panmure Gordon
www.americanbankingnews.com - May 22 at 10:20 PM |
| BTG plc (BTG) Stock Rating Reaffirmed by Numis Securities Ltd
www.americanbankingnews.com - May 22 at 4:28 PM |
 | OPTALYSE PE Study Demonstrates Safety and Efficacy of Shorter, Lower Dose EKOS ® Therapy For Pulmonary Embolism
www.businesswire.com - May 22 at 12:48 PM |
 | BTG EKOS Trial Data Supports Shorter Treatment And Smaller Doses
www.morningstar.co.uk - May 22 at 12:48 PM |
| Did the Fall in Equities on May 17 Help Precious Metals?
finance.yahoo.com - May 19 at 4:00 PM |
| Did the Fall in Equities on May 17 Help Precious Metals?
finance.yahoo.com - May 19 at 4:00 PM |
| BTG and HealthLoop Collaborate on IO Loop™, an Exclusive Service to Connect Patients and Interventional Oncologists Throughout Treatment
finance.yahoo.com - May 19 at 9:00 AM |
| Could Physical Gold Demand Rescue Gold Prices?
finance.yahoo.com - May 19 at 9:00 AM |
| JPMorgan Chase & Co. Cuts BTG plc (BTG) Price Target to GBX 750
www.americanbankingnews.com - May 18 at 10:20 PM |
| BTG plc's (BTG) Buy Rating Reiterated at Deutsche Bank AG
www.americanbankingnews.com - May 18 at 5:20 PM |
 | BTG's (BTGGF) CEO Louise Makin on Full Year 2017 - Earnings Call Transcript
seekingalpha.com - May 16 at 9:09 PM |
| Edited Transcript of BTG.L earnings conference call or presentation 16-May-17 8:30am GMT
finance.yahoo.com - May 16 at 9:09 PM |
| BTG shares fall as revenue outlook fails to please - MarketWatch
www.marketwatch.com - May 16 at 4:08 PM |
| Earnings drag on European shares, though Vodafone lifts telcos
finance.yahoo.com - May 16 at 4:08 PM |
| BTG profit falls even as use of Varithena rises - MarketWatch
www.marketwatch.com - May 16 at 9:18 AM |
| BTG plc's (BTG) Hold Rating Reiterated at Peel Hunt
www.americanbankingnews.com - May 16 at 6:04 AM |
| How Silver-Based Funds Plunged Their Way through April 2017
finance.yahoo.com - May 10 at 4:17 PM |
| [$$] Micro Focus warns on revenues at HPE software unit ahead of deal
finance.yahoo.com - May 9 at 9:08 PM |
| BTG plc (BTG) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - May 4 at 1:32 AM |
BTG plc (BTG) Chart for Sunday, August, 20, 2017
